Shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $5.50, but opened at $5.62. LifeStance Health Group shares last traded at $5.52, with a volume of 34,881 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Morgan Stanley reaffirmed an “overweight” rating and set a $10.00 target price on shares of LifeStance Health Group in a report on Monday, April 22nd. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $8.80.
Read Our Latest Stock Analysis on LifeStance Health Group
LifeStance Health Group Price Performance
Want More Great Investing Ideas?
The stock has a 50-day moving average of $5.66 and a two-hundred day moving average of $6.24. The company has a market cap of $2.10 billion, a P/E ratio of -11.46 and a beta of 1.20. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.18 and a current ratio of 1.18.
LifeStance Health Group (NASDAQ:LFST – Get Free Report) last released its earnings results on Thursday, May 9th. The company reported ($0.06) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.03. The company had revenue of $300.44 million during the quarter, compared to the consensus estimate of $299.02 million. LifeStance Health Group had a negative return on equity of 11.92% and a negative net margin of 15.69%. LifeStance Health Group’s quarterly revenue was up 18.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.09) EPS. On average, research analysts anticipate that LifeStance Health Group, Inc. will post -0.26 EPS for the current fiscal year.
Insider Activity
In other news, major shareholder Summit Partners Growth Equity sold 3,802,345 shares of the stock in a transaction that occurred on Friday, May 24th. The stock was sold at an average price of $5.89, for a total transaction of $22,395,812.05. Following the completion of the sale, the insider now owns 41,932,358 shares of the company’s stock, valued at $246,981,588.62. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, major shareholder Summit Partners Growth Equity sold 3,802,345 shares of the stock in a transaction that occurred on Friday, May 24th. The stock was sold at an average price of $5.89, for a total transaction of $22,395,812.05. Following the completion of the sale, the insider now owns 41,932,358 shares of the company’s stock, valued at $246,981,588.62. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Danish J. Qureshi sold 150,000 shares of the stock in a transaction that occurred on Friday, June 14th. The shares were sold at an average price of $5.21, for a total value of $781,500.00. Following the sale, the insider now directly owns 439,002 shares of the company’s stock, valued at approximately $2,287,200.42. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 4,087,716 shares of company stock valued at $24,010,444. 6.60% of the stock is currently owned by company insiders.
Institutional Trading of LifeStance Health Group
A number of institutional investors and hedge funds have recently added to or reduced their stakes in LFST. Vanguard Group Inc. lifted its stake in LifeStance Health Group by 1.1% in the third quarter. Vanguard Group Inc. now owns 7,525,195 shares of the company’s stock worth $51,698,000 after acquiring an additional 84,373 shares during the period. SG Americas Securities LLC lifted its stake in LifeStance Health Group by 37.6% in the fourth quarter. SG Americas Securities LLC now owns 41,325 shares of the company’s stock worth $324,000 after acquiring an additional 11,295 shares during the period. Stratos Wealth Partners LTD. purchased a new stake in LifeStance Health Group in the fourth quarter worth $93,000. Charles Schwab Investment Management Inc. lifted its stake in LifeStance Health Group by 0.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 744,617 shares of the company’s stock worth $5,830,000 after acquiring an additional 5,112 shares during the period. Finally, Principal Financial Group Inc. lifted its stake in LifeStance Health Group by 2.8% in the fourth quarter. Principal Financial Group Inc. now owns 4,006,344 shares of the company’s stock worth $31,370,000 after acquiring an additional 110,457 shares during the period. Hedge funds and other institutional investors own 85.50% of the company’s stock.
LifeStance Health Group Company Profile
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Further Reading
- Five stocks we like better than LifeStance Health Group
- How to Effectively Use the MarketBeat Ratings Screener
- Why This AI Stock is Rising Despite Tech Sell-Off
- Are Penny Stocks a Good Fit for Your Portfolio?
- Investors Are Moving into Bonds and Small Cap Stocks: Here’s Why
- Health Care Stocks Explained: Why You Might Want to Invest
- MarketBeat Week in Review – 7/15 – 7/19
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
